Abstract
The last two decades have witnessed a substantial decline in mortality due to myocardial infarction and stroke. However, during a similar period, data obtained from the National Center for Health Statistics indicate that the number of deaths due to congestive heart failure (CHF) has increased more than four-fold; for example, the number of deaths in which CHF was considered to be the underlying cause increased from about 6000 in 1955 to over 30,000 by 1982. There was a parallel increase in the number of deaths in which CHF was considered to be a contributing cause, from 51,000 in 1955 to about 246,000 in 1982. Although a substantial part of this increase can be explained by the aging of the population, the age-adjusted death rates also show a two-fold increase. For example, the age adjusted death rates, where CHF was the underlying cause, increased from 3.5/100,000 in 1968 to about 7.5/100,000 by 1984. The incidence of CHF and deaths due to CHF increased exponentially with age in both sexes and all races. However for any specific age group, CHF mortality is about 1.6 times commoner in men and about two to three times commoner in blacks compared to whites.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Applefeld MM: Chronic Congestive Heart Failure: Where have we been? Where are we heading? Am J Med 80 Suppl 2B: 73–77, 1986.
McKee PA, Castelli WP, McNamara PM, et al: The natural history of congestive heart failure: The Framingham Study. N Engl J Med 285: 1441–1446, 1971.
Fisher LD, Alderman EL, Mock MB, Chaitman BR, Ringqvist I, Ryan TJ, Levine F, Kaiser GC, Schloss M, Killip T, Oberman A, Litwin P: Statistical Considerations in Evaluating Treatment of Advanced Congestive heart failure. In Congestive Heart Failure. Ed Braunwald E, Mock MB and Watson JT: p 357–366. Grune and Stratton Inc., 1982
Wilson JR, Schwartz JS, St. John-Sutton M, et al: Prognosis in severe heart failure: Relation to hemodynamic measurements and ventricular ectopic activity. J Amer Coll Cardiol 2: 403–410, 1983.
Cohn JN, Archibald DG, Ziesche S, et al: Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 314: 1547–1552, 1986.
Franciosa JA, Wilen M, Ziesche S and Cohn JN: Survival in Men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 51: 831–835, 1983.
Schwarz F, Mall G, Zebe H, et al: Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics. Circulation 70: 923–928, 1984.
Fuster V, Gersh BJ, Giuliani ER, et al: The Natural History of Idiopathic Dilated Cardiomyopathy. Am J Cardiol 47: 525–531, 1981.
Massie B, Ports T, Chatterjee K, et al: Long-term vasodilator therapy for heart failure: Clinical Response and its relationship to hemodynamic measurements. Circulation 63: 269–278, 1981.
Unverferth DV, Magorien RD, Moeschberg ML, et al: Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 54: 147–152, 1984.
Studies of Left Ventricular Dysfunction — Protocol, 1986.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Yusuf, S., Thom, T., Probstfield, J. (1987). The Public Health and Clinical Implications of the National Increase in Congestive Heart Failure. In: Morganroth, J., Moore, E.N. (eds) Congestive Heart Failure. Developments in Cardiovascular Medicine, vol 75. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2077-7_1
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2077-7_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9232-6
Online ISBN: 978-1-4613-2077-7
eBook Packages: Springer Book Archive